21 December 2009
Effects of blue-green algae extracts on the proliferation of human adult stem cells in vitro: a preliminary studyDouglas R ShytleACDEF, Jun TanACDEF, Jared EhrhartBCEF, Adam J SmithBCEF, Cyndy D SanbergAE, Paul R SanbergAE, Jerry AndersonAE, Paula C BickfordACEF
Med Sci Monit 2010; 16(1): BR1-5 :: ID: 878300
Adult stem cells are known to have a reduced restorative capacity as we age and are more vulnerable to oxidative stress resulting in a reduced ability of the body to heal itself. We have previously reported that a proprietary nutraceutical formulation, NT-020, promotes proliferation of human hematopoietic stem cells in vitro and protects stem cells from oxidative stress when given chronically to mice in vivo. Because previous reports suggest that the blue green algae, Aphanizomenon flos-aquae (AFA) can modulate immune function in animals, we sought to investigate the effects of AFA on human stem cells in cultures.
Material and Method
Two AFA products were used for extraction: AFA whole (AFA-W) and AFA cellular concentrate (AFA-C). Water and ethanol extractions were performed to isolate active compounds for cell culture experiments. For cell proliferation analysis, human bone marrow cells or human CD34+ cells were cultured in 96 well plates and treated for 72 hours with various extracts. An MTT assay was used to estimate cell proliferation.
We report here that the addition of an ethanol extract of AFA-cellular concentrate further enhances the stem cell proliferative action of NT-020 when incubated with human adult bone marrow cells or human CD34+ hematopoietic progenitors in culture. Algae extracts alone had only moderate activity in these stem cell proliferation assays.
This preliminary study suggests that NT-020 plus the ethanol extract of AFA cellular concentrate may act to promote proliferation of human stem cell populations.
Keywords: Tetrazolium Salts, Complex Mixtures - pharmacology, Cell Proliferation - drug effects, Bone Marrow Cells - drug effects, Aphanizomenon - chemistry, Adult Stem Cells - drug effects, Thiazoles
01 February 2024 : EditorialEditorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise
Med Sci Monit 2024; 30:e943911
08 Feb 2024 : Clinical ResearchPredictors of Mortality in Veterans with Amyotrophic Lateral Sclerosis: Respiratory Status and Speech Disor...
Med Sci Monit In Press; DOI: 10.12659/MSM.943288
25 Feb 2024 : Clinical ResearchPatterns and Outcomes of Traumatic Suicides: A Retrospective Study of 132 Patients Admitted to a Turkish Me...
Med Sci Monit In Press; DOI: 10.12659/MSM.943505
01 Feb 2024 : Review articleReview of the Evaluation of Pulmonary Hypoplasia as an Important Determinant of Clinical Outcomes in Infant...
Med Sci Monit In Press; DOI: 10.12659/MSM.943259
Most Viewed Current Articles
16 May 2023 : Clinical ResearchElectrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review articleVaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990